The Federal Register

National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting

Thu, Jul 3 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; Deferred AA3 Applications.

Date: July 16, 2008.

Time: 1 to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 5635 Fishers Lane, Room 3042, Rockville, MD 20852 (Telephone Conference Call).

Contact Person: Katrina L. Foster,

Training of Latin American Health-Care Workers Through the Gorgas Memorial Institute, Republic of Panama

Thu, Jul 3 2008 11:00:00 GMT

This project will support the Gorgas Memorial Institute (GMI) to: (a) Develop a regional training center in Panama and (b) train community health workers, clinicians (physicians, nurses, and auxiliary medical workers) and select publichealth professionals from Central and South America (i.e., Latin America), (c) facilitate partnerships between U.S. universities and their Latin American counterparts to develop human resources for health in Latin America, and (d) harness the energies of U.S. and other nongovernmental organizations by partnering with them to advance community healthtraining and program efforts in Latin America.

These efforts will help engage significantly more areas of these countries to prepare for and respond to publichealth emergencies, such as pandemic influenza, and they will contribute to the improved and expanded provision of prevention and primary health care. This training of nurses, community health workers and physicians will focus on improving and expanding coverag

Office of the Director, National Institutes of Health; Office of Biotechnology Activity; Recombinant DNA Research;

Thu, Jul 3 2008 11:00:00 GMT

There will be a working group meeting of the NIH Blue Ribbon Panel to advise on the Risk Assessment of the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University Medical Center.

The meeting will be held on Wednesday, July 16, 2008, at the National Institutes of Health, Building 31, 31 Center Drive, Floor 6C, Room 6, Bethesda, MD 20892 from approximately 8 a.m. to 1 p.m.

Discussions will focus on risk communications and the general principles and strategies for effective community outreach and engagement.

For further information concerning this meeting contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of Biotechnology Activities, Office of the Director, National Institutes of Health, Mail Stop Code 7985, Bethesda, MD 208927985, telephone 3014969838, email lewallla@od.nih.gov.

Background information may be obtained by contacting NIH OBA by email oba@od.nih.gov.

Agency Forms Undergoing Paperwork Reduction Act Review

Thu, Jul 3 2008 11:00:00 GMT

The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 6395960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 3956974. Written comments should be received within 30 days of this notice. Proposed Project

Health Hazard Evaluation and Technical AssistanceRequests and Emerging ProblemsReinstatement (OMB No. 09200260)National
Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

In accordance with its mandates under the Occupational Safety and Health Act of 1970 and the Federal Mine Safety and Health Act of 1977, the Natio

Agency Forms Undergoing Paperwork Reduction Act Review

Thu, Jul 3 2008 11:00:00 GMT

Work Organization Predictors of Depression in Women ReinstatementThe National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description

Depression is a costly and debilitating occupational health problem. Research has indicated that the costs to an organization of treatment for depression can rival those for heart disease, a

Proposed Data Collections Submitted for Public Comment and Recommendations

Thu, Jul 3 2008 11:00:00 GMT

In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed project or to obtain a copy of data collection plans and instruments, call the CDC Reports Clearance Officer on 4046395960 or send comments to CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS D74, Atlanta, GA 30333 or send an email to omb@cdc.gov.

Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information

Study Team for the Los Alamos Historical Document Retrieval and Assessment (LAHDRA) Project

Thu, Jul 3 2008 11:00:00 GMT

The Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR) announces the following meeting.

Name: Public Meeting of the Study Team for the Los Alamos Historical Document Retrieval and Assessment Project.

Time and Date: 5 p.m.7 p.m., (Mountain Time), Wednesday, July 23, 2008.

Place: Cities of Gold Hotel, Nambe Conference Room, Cities of Gold Road exit in Pojoaque (15 miles north of Santa Fe on U.S. 84/285), 10A Cities of Gold Road, Santa Fe, New Mexico 87506, telephone (505) 455 0515, fax (505) 4553060.

Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 200 people.

Background: Under a Memorandum of Understanding (MOU) signed in December 1990 with the Department of Energy (DOE) and replaced by MOUs signed in 1996 and 2000, the Department of Health and Human Services (HHS) was given the responsibility and resources for conducting analytic epidemiologic investiga

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Thu, Jul 3 2008 11:00:00 GMT

Agency Information Collection Activities: Proposed Collection; Comment Request

Thu, Jul 3 2008 11:00:00 GMT

Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

Thu, Jul 3 2008 11:00:00 GMT

The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories currently certified to meet the standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on April 13, 2004 (69 FR 19644).

A notice listing all currently certified laboratories is published in the Federal Register during the first week of each month. If any laboratory's certification is suspended or revoked, the laboratory will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines.

If any laboratory has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end, and will be omitted fro

Submission for OMB Review; Comment Request; The Agricultural Health Study: A Prospective Cohort Study of Cancer and

Thu, Jul 3 2008 11:00:00 GMT

Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Cancer Institute (NCI), the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request to review and approve the information collection listed below. This proposed information collection was previously published in the Federal Register on April 30, 2008 (Vol. 73, No. 84, p. 23473), and allowed 60 days for public comment. No public comments or questions were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an
[[Page 38228]]
information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.

Proposed Collection: Title: The Agricultural Health Study: A Prospective Cohort Study of Cancer and Other Disease Among Me

Government-Owned Inventions; Availability for Licensing

Thu, Jul 3 2008 11:00:00 GMT

The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federallyfunded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.

Government-Owned Inventions; Availability for Licensing

Thu, Jul 3 2008 11:00:00 GMT

Public Teleconference Regarding Licensing and Collaborative Research Opportunities for: Methods and Compositions

Thu, Jul 3 2008 11:00:00 GMT

Technology Summary

This technology relates to a method of detecting DPD Splicing Mutations.

Technology Description

Scientists at the National Cancer Institute have discovered a method detecting DPD Splicing Mutations. This method can identify patients with such mutations, and thereby alert the health care provider that the patient will have an adverse reaction to the chemotherapeutic agent, 5Fluorouracil.

The invention relates to methods and compositions that are useful for detecting deficiencies in DPD levels in mammals including humans. Cancer patients having a DPD deficiency are at risk of a severe toxic reaction to the commonly used anticancer agent 5fluorouracil (5FU). The technology encompasses DPD genes from human and pig, methods for detecting the level of nucleic acids that encode DPD in a patient, and nucleic acids that are useful as probes for this purpose.

Novel applications of the methods include:

Screening of patients prior to the administration of the c

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

Thu, Jul 3 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Kidney Diseases Mentored Career Applications Review.

Date: July 25, 2008.

Time: 3 p.m. to 4:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

Thu, Jul 3 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Lesch Nyhan Disease Interdisciplinary Studies.

Date: July 28, 2008.

Time: 10:30 a.m. to 1 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Teleph

New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition

Thu, Jul 3 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is issuing an order prohibiting the extralabel use of cephalosporin antimicrobial drugs in foodproducing animals. We are issuing this order based on evidence that extralabel use of these drugs in foodproducing animals will likely cause an adverse event in humans and, as such, presents a risk to the public health.

National Institute of General Medical Sciences; Notice of Closed Meetings

Thu, Jul 3 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Centers of Excellence in Chemical Methodologies and Library Development.

Date: July 2223, 2008.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, National Institute of General Medical Sciences, Building 45, Room

Office of the National Coordinator for Health Information Technology; American Health Information Community Meeting

Wed, Jul 2 2008 11:00:00 GMT

This notice announces the meeting date for the 23rd meeting of the American Health Information Community in accordance with the Federal Advisory Committee Act (Pub. L. No. 92463, 5 U.S.C., App.) The American Health Information Community will advise the Secretary and recommend specific actions to achieve a common interoperability framework for health information technology (IT).

Meeting Date: July 29, 2008, from 8:30 a.m. to 2 p.m. (Eastern).

Submission of Quality Information for Biotechnology Products in the Office of Biotechnology Products; Notice of Pilot

Wed, Jul 2 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is seeking volunteers from pharmaceutical companies to participate in a pilot
[[Page 37973]]
program involving the submission of quality (chemistry, manufacturing, and controls) information for biotechnology products in an Expanded Change Protocol, consistent with the principles of quality by design and risk management in pharmaceutical manufacturing. The purpose of the pilot program is to gain more information on and facilitate agency review of qualitybydesign, riskbased approaches for manufacturing biotechnology products. This pilot will focus on products reviewed by FDA's Office of Biotechnology Products (OBP), in the Office of Pharmaceutical Science (OPS), Center for Drug Evaluation and Research (CDER). This pilot program will assist FDA in developing guidance for industry on quality by design and risk management in pharmaceutical manufacturing. The pilot is open to original submissions of and supplements to biologic license applications (BLA) or new d

Danisco USA, Inc.; Withdrawal of Food Additive Petition; Correction

Wed, Jul 2 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is correcting a document announcing the withdrawal, without prejudice to a future filing, of a food additive petition (FAP 6A3958) that appeared in the Federal Register of June 20, 2008. FDA is correcting the addresses of both Pfizer, Inc., and Danisco USA, Inc.

National Institute of Child Health and Human Development; Notice of Closed Meeting

Wed, Jul 2 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Multiple Study Data Coordinating Center for DESPR.

Date: July 14, 2008.

Time: 10 a.m. to 4:30 p.m.

Agenda: To review and evaluate contract proposals.

Place: Crowne Plaza Washington National Airport, 1489 Jefferson Davis Hwy, Arlington, VA 22202.

Contact Person:

National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting

Wed, Jul 2 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute on Alcohol Abuse and Alcoholism

Special Emphasis Panel: Review of Deferred Applications.

Date: August 6, 2008.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 5635 Fishers Lane, Room 3043, Rockville, MD 20852, (Telephone Conference Call).

Contact Person: Lo

Submission for OMB Review; Comment Request; Partner and Customer Satisfaction Surveys

Wed, Jul 2 2008 11:00:00 GMT

Under the provisions of Section 3507(a)(l)(D) of the Paperwork Reduction Act of 1995 for the opportunity for public comment on the proposed data collection projects, the Center for Scientific Review (CSR), National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request to review and approve the information collection listed below. The purpose of this notice is to allow 30 days for public comment. The National Institutes of Health may not conduct or sponsor and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.

National Institute for Occupational Safety and Health; Designation of a Class of Employees for Addition to the Special

Tue, Jul 1 2008 11:00:00 GMT

The Department of Health and Human Services (HHS) gives notice of a decision to designate a class of employees at the Kellex/Pierpont facility in Jersey City, New Jersey, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On May 30, 2008, the Secretary of HHS designated the following class of employees as an addition to the SEC:

All Atomic Weapons Employer (AWE) employees who worked at the Kellex/Pierpont facility in Jersey City, New Jersey, from January 1, 1943, through December 31, 1953, for a number of work days aggregating at least 250 work days occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.

This designation will become effective on June 29, 2008, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice i

National Institute for Occupational Safety and Health; Designation of a Class of Employees for Addition to the Special

Tue, Jul 1 2008 11:00:00 GMT

The Department of Health and Human Services (HHS) gives notice of a decision to designate a class of employees at SAM (Special Alloyed or Substitute Alloy Materials) Laboratories of Columbia University, in New York City, New York, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On May 30, 2008, the Secretary of HHS designated the following class of employees as an addition to the SEC:

All employees of the Department of Energy (DOE), its predecessor agencies, and DOE contractors or subcontractors who worked in the Pupin, Schemerhorn, Havenmeyer, Nash, or Prentiss buildings at SAM (Special Alloyed or Substitute Alloy Materials) Laboratories of Columbia University in New York City, New York, from August 13, 1942, through December 31, 1947, for a number of work days aggregating at least 250 work days occurring either solely under this employment or in combination with work days within the parameters establishe

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Extension of Certification on

Tue, Jul 1 2008 11:00:00 GMT

The Administration on Aging (AoA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

National Institute for Occupational Safety and Health; Designation of a Class of Employees for Addition to the Special

Tue, Jul 1 2008 11:00:00 GMT

The Department of Health and Human Services (HHS) gives notice of a decision to designate a class of employees at the Hanford Nuclear Reservation in Richland, Washington, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On May 30, 2008, the Secretary of HHS designated the following class of employees as an addition to the SEC:

All employees of the Department of Energy (DOE), its predecessor agencies, and DOE contractors or subcontractors who worked from:

1. September 1, 1946 through December 31, 1961 in the 300 area; or

2. January 1, 1949 through December 31, 1968 in the 200 areas (East and West) at the Hanford Nuclear Reservation in Richland, Washington, for a number of work days aggregating at least 250 work days occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.

Statement of Organization, Functions, and Delegations of Authority

Tue, Jul 1 2008 11:00:00 GMT

Part F of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS), (Federal Register , Vol. 73, No. 46, pp. 1245112452, dated Friday, March 7, 2008) is amended to reflect a change in the name and updates to the functions for the Center for Beneficiary Choices.

Part F. is described below:

Section F. 20. (Functions) reads as follows:
Center for Drug and Health Plan Choice (FAE)

Responsible for all national policies and operations necessary for the purchasing of Medicare Prescription Drug (Part D) and Medicare Advantage (Part C) health plan benefits. Designs, implements, and manages the procurement of prescription drug plans (PDPs) and Medicare Advantage plans (MA and MAPD plans), including the solicitation and approval of applications, review of benefits and negotiation of competitive bids, the implementation of quality improvement and performance measures

National Institute for Occupational Safety and Health; Designation of a Class of Employees for Addition to the Special

Tue, Jul 1 2008 11:00:00 GMT

The Department of Health and Human Services (HHS) gives notice of a decision to designate a class of employees at the Horizons Inc. facility, Cleveland, Ohio, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On May 30, 2008, the Secretary of HHS designated the following class of employees as an addition to the SEC:

All Atomic Weapons Employer (AWE) employees who worked at the Horizons, Inc. facility from January 1, 1952, through December 31, 1956, for a number of work days aggregating at least 250 work days occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.

This designation will become effective on June 29, 2008, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addi

National Institute for Occupational Safety and Health; Designation of a Class of Employees for Addition to the Special

Tue, Jul 1 2008 11:00:00 GMT

The Department of Health and Human Services (HHS) gives notice of a decision to designate a class of employees at the Nuclear Materials and Equipment Corporation (NUMEC) facility, Parks Township, Pennsylvania, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On May 30, 2008, the Secretary of HHS designated the following class of employees as an addition to the SEC:

All Atomic Weapons Employer (AWE) employees who worked at the Nuclear Materials and Equipment Corporation (NUMEC) facility in Parks Township, Pennsylvania, from June 1, 1960, through December 31, 1980, for a number of work days aggregating at least 250 work days occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.

This designation will become effective on June 29, 2008, unless Congress provides otherwise prior

Request for Information and Comments on the Implementation of Human Subjects Protection Training and Education

Tue, Jul 1 2008 11:00:00 GMT

The Office for Human Research Protections (OHRP), Office of Public Health and Science is seeking information and comments from affected entities and individuals about (a) Whether OHRP should issue additional guidance recommending that institutions engaged in human subjects research conducted or supported by the Department of Health and Human Services (HHS) implement training and education programs for certain individuals involved in the conduct, review, or oversight of human subjects research, or (b) whether HHS should develop a regulation requiring the implementation of such training and education programs. This request for information and comment stems from the 1998 report from the HHS Office of Inspector General (OIG) recommending that Federal requirements be enacted to help ensure that investigators and institutional review board (IRB) members be adequately educated about, and sensitized to, human subjects protections. More recently, the Secretary's Advisory Committee on Human Research Prot

Center for Scientific Review; Notice of Closed Meetings

Tue, Jul 1 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

Name of Committee: Center for Scientific Review Special Emphasis Panel, Review of Applications for RFA: International Research on VenueBased Interventions for HIV/AIDS and Alcohol Use.

Date: July 1618, 2008

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Vir

Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Request for

Tue, Jul 1 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Request for Designation as Country not Subject to the Restrictions Applicable to Human Food and Cosmetics Manufactured from, Processed With, or Otherwise Containing, Material from Cattle'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Tue, Jul 1 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Allergy and Infectious Diseases Special
[[Page 37470]]
Emphasis Panel; Operation of a Facility for the Study of Infectious Agents, Vaccines and Antimicrobials in Adult and Pediatric Human Subjects.

Date: July 21, 2008.

Time: 9 a.m. to 12 p.m.

Agenda: To review and evaluate contract proposals.

Place: National Institutes of H

Agency Information Collection Activities; Proposed Collection; Comment Request; Mental Models Study of Farmers'

Tue, Jul 1 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for public comment in response to the notice. This notice solicits comments on the proposed study entitled ``Mental Models Study of Farmers' Understanding and Implementation of Good Agricultural Practices.''

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request;

Tue, Jul 1 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing [[Page 37466]]
that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Innovative Food Defense Projects; New Limited Competition Cooperative Agreement U13; Request for Application Number:

Tue, Jul 1 2008 11:00:00 GMT

The Food and Drug Administration (FDA), Office of Regulatory Affairs (ORA), Division of FederalState Relations (DFSR) is announcing the availability of grant funds for the support of innovative food defense projects. These grants are available to State, local, and tribal levels and must have national implication or application that can enhance Federal, State, and local food regulatory programs and are likely to impact preparedness, response and/or recovery. FDA anticipates providing approximately $240,000 in direct plus indirect costs in support of this program in fiscal year 2008. It is anticipated that 6 awards will be made for up to $40,000 per award/per year for up to 1 year.

National Institute of Mental Health; Notice of Closed Meeting

Mon, Jun 30 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel; Fellowships and Dissertation Grants II.

Date: July 23, 2008.

Time: 2 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

Contact Person

National Institute of Mental Health; Notice of Closed Meeting

Mon, Jun 30 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Mental Health Special Emphasis Panel; Community Based Participatory Research.

Date: July 16, 2008.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

Contact Perso

Cooperative Agreement to Establish and Support the Western Center for Food Safety (U01)

Mon, Jun 30 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing a Request for Application (RFA) Number RFAFD08004 and its intention to receive and consider a new sole source application for the award of a cooperative agreement in fiscal year 2008 (FY 2008) to establish and support the Western Center for Food Safety (WCFS). The WCFS will be located at the Western Institute for Food Safety and Security (WIFSS) on the University of California, Davis (UCD) campus in Davis, CA.

Food Protection Rapid Response Team and Program Infrastructure Improvement Prototype Project (U18); Availability of

Mon, Jun 30 2008 11:00:00 GMT

I. Research Objectives

The Food and Drug Administration (FDA), Office of Regulatory Affairs (ORA), Division of FederalState Relations (DFSR) in collaboration with the Center for Food Safety and Applied Nutrition (CFSAN) and Center for Veterinary Medicine (CVM), is announcing the availability of an Agreement of Limited Competition. Only States with current FDA Food Safety contracts to provide funding to State agency food protection regulatory programs are eligible for a 3year cooperative agreement to develop and sustain an all Food Hazards Rapid Response Team, encompassing both food and feed protection programs, through a process to further enhance and build the infrastructure of State food protection programs.

The goal of FDA's ORA Cooperative Agreement Program is to enhance, complement, develop and improve State manufactured food protection regulatory and surveillance programs. This will be accomplished through the provision of funding for program assessment, additional equipment, supp

National Institute of General Medical Sciences; Notice of Closed Meetings

Mon, Jun 30 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; NRSA Institutional Research Training.

Date: July 22, 2008.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency, One Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Brian R Pike, PhD, Scientific Review Officer, Of

Prescription Drug User Fee Act IV Information Technology Plan

Mon, Jun 30 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing the availability of the information technology (IT) Plan entitled ``Prescription Drug User Fee Act (PDUFA) IV Information Technology Plan'' to achieve the objectives defined in the PDUFA Performance Goals. This plan is intended to provide regulated industry and other stakeholders with information on FDA's vision and plan for improving the automation of business processes and maintaining information systems that support the review process of human drug applications.

Medicare and Medicaid Programs; Hospital Conditions of Participation: Laboratory Services

Fri, Jun 27 2008 11:00:00 GMT

This final rule finalizes the hospital conditions of participation requirements for hospitals that transfuse blood and blood components. It requires hospitals to: Prepare and follow written procedures for appropriate action when it is determined that blood and blood components the hospitals received and transfused are at increased risk for transmitting hepatitis C virus (HCV); quarantine prior collections from a donor who is at increased risk for transmitting HCV infection; notify transfusion recipients, as appropriate, of the need for HCV testing and counseling; and extend the records retention period for transfusionrelated data to 10 years. The intent is to aid in the prevention of HCV infection and to create opportunities for disease prevention that, in most cases, can occur many years after recipient exposure to a donor.

Center for Scientific Review; Notice of Closed Meetings

Fri, Jun 27 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

Name of Committee: Center for Scientific Review Special Emphasis Panel, Core Instrumentation.

Date: July 1415, 2008.

Time: 8 a.m. to 4:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

Contact Person: Joseph D. Mosca, PhD, Scientific Review Officer, Cen

Medicare Program; Appeals of CMS or CMS Contractor Determinations When a Provider or Supplier Fails to Meet the

Fri, Jun 27 2008 11:00:00 GMT

This final rule implements a number of regulatory provisions that are applicable to all providers and suppliers, including durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) suppliers. This final rule establishes appeals processes for all providers and suppliers whose enrollment, reenrollment or revalidation application for Medicare billing privileges is denied and whose Medicare billing privileges are revoked. It also establishes timeframes for deciding enrollment appeals by an Administrative Law Judge (ALJ) within the Department of Health and Human Services (DHHS) or the Departmental Appeals Board (DAB), or Board, within the DHHS; and processing timeframes for CMS' Medicare feeforservice (FFS) contractors.

In addition, this final rule allows Medicare FFS contractors to revoke Medicare billing privileges when a provider or supplier submits a claim or claims for services that could not have been furnished to a beneficiary. This final rule also specifies that a Medicare

National Institute on Drug Abuse; Notice of Closed Meeting

Fri, Jun 27 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Conference Grant Review Committee.

Date: July 18, 2008.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).

Contact Person: Mark R. Green, PhD, Deputy Director, O

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request;

Fri, Jun 27 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Medicare Program; Special Enrollment Period and Medicare Premium Changes

Fri, Jun 27 2008 11:00:00 GMT

This final rule provides a special enrollment period (SEP) for Medicare Part B and premium Part A for certain individuals who are sponsored by prescribed organizations as volunteers outside of the United States and who have health insurance that covers them while outside the United States. Under the SEP provision, qualifying volunteers can delay enrollment in Part B and premium Part A, or terminate such coverage, for the period of service outside of the United States and reenroll without incurring a premium surcharge for late enrollment or reenrollment.

This final rule also codifies provisions that require certain beneficiaries to pay an incomerelated monthly adjustment amount (IRMAA) in addition to the standard Medicare Part B premium, plus any applicable increase for late enrollment or reenrollment. The income related monthly adjustment amount is to be paid by beneficiaries who have a modified adjusted gross income that exceeds certain threshold amounts. It also represents the amount of de

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; New

Fri, Jun 27 2008 11:00:00 GMT

Medicare Program; Use of Repayment Plans

Fri, Jun 27 2008 11:00:00 GMT

This final rule modifies Medicare regulations to implement section 935(a) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 pertaining to the use of repayment plans (also known as extended repayment schedules or ``ERS'') for Medicare provider and supplier overpayments. Under this provision, we are granting a provider or a supplier an ERS under certain terms and conditions as defined in the statute. This final rule establishes criteria and procedures to apply this requirement and to define the concepts of ``hardship'' and ``extreme hardship.''

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request;

Fri, Jun 27 2008 11:00:00 GMT

Medicare Program; Changes in Conditions of Participation Requirements and Payment Provisions for Rural Health Clinics

Fri, Jun 27 2008 11:00:00 GMT

This proposed rule would establish location requirements including exception criteria for rural health clinics (RHCs). It would also require RHCs to establish a quality assessment and performance improvement (QAPI) program. In addition, it would: Clarify our policies on ``commingling'' of an RHC with another entity; revise the RHC and Federally Qualified Health Centers (FQHC) payment methodology and exceptions to the pervisit payment limit to implement statutory requirements; revise RHC and FQHC payment requirements for services furnished to skilled nursing facility (SNF) patients; allow RHCs to contract with RHC nonphysician providers under certain circumstances; and update the regulations pertaining to waivers to the staffing requirements. This proposed rule would also add requirements for RHCs and FQHCs to maintain and document an infection control process and to post RHC or FQHC hours of clinical services. In addition, this proposed rule would update the requirements under the emergency ser

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request;

Fri, Jun 27 2008 11:00:00 GMT

Medicare and Medicaid Programs; Quarterly Listing of Program Issuances--January Through March 2008

Fri, Jun 27 2008 11:00:00 GMT

This notice lists CMS manual instructions, substantive and interpretive regulations, and other Federal Register notices that were published from January 2008 through March 2008, relating to the Medicare and Medicaid programs. This notice provides information on national coverage determinations (NCDs) affecting specific medical and health care services under Medicare. Additionally, this notice identifies certain devices with investigational device exemption (IDE) numbers approved by the Food and Drug Administration (FDA) that potentially may be covered under Medicare. This notice also includes listings of all approval numbers from the Office of Management and Budget for collections of information in CMS regulations and a list of Medicareapproved carotid stent facilities. Included in this notice is a list of the American College of Cardiology's National Cardiovascular Data registry sites, active CMS coveragerelated guidance documents, and special onetime notices regarding national coverage provis

Medicare and Medicaid Programs; The Joint Commission for Continued Deeming Authority for Ambulatory Surgical Centers

Fri, Jun 27 2008 11:00:00 GMT

This proposed notice acknowledges the receipt of a deeming application from the Joint Commission for continued recognition as a national accrediting organization for ambulatory surgical centers (ASCs) that wish to
[[Page 36519]]
participate in the Medicare or Medicaid programs. Section 1865(b)(3)(A) of the Social Security Act requires that within 60 days of receipt of an organization's complete application, we publish a notice that identifies the national accrediting body making the request, describes the nature of the request, and provides at least a 30day public comment period.

Medicare and Medicaid Programs; Application by the Accreditation Association for Ambulatory Health Care for Continued

Fri, Jun 27 2008 11:00:00 GMT

This proposed notice acknowledges the receipt of a deeming application from the Accreditation Association for Ambulatory Health Care (AAAHC) for continued recognition as a national accrediting organization for ambulatory surgical centers (ASCs) that wish to participate in the Medicare or Medicaid programs. Section 1865(b)(3)(A) of the Social Security Act requires that within 60 days of receipt of an organization's complete application, we publish a notice that identifies the national accrediting body making the request, describes the nature of the request, and provides at least a 30day public comment period.

Medicare Program; Criteria and Standards for Evaluating Intermediary and Carrier Performance During Fiscal Year 2009

Fri, Jun 27 2008 11:00:00 GMT

This general notice with comment period describes the criteria and standards to be used for evaluating the performance of fiscal intermediaries (FIs) and carriers in the administration of the Medicare program. The results of these evaluations are considered whenever we enter into, renew, or terminate a FI agreement, carrier contract, or take other contract actions, for example, assigning or reassigning providers or services to a FI or designating regional or national intermediaries. We are requesting public comment on these criteria and standards.

Medicare Program; Second Semi-Annual Meeting of the Advisory Panel on Ambulatory Payment Classification

Fri, Jun 27 2008 11:00:00 GMT

In accordance with section 10(a) of the Federal Advisory Committee Act (FACA) (5 U.S.C. Appendix 2), this notice announces the second semiannual meeting of the Advisory Panel on Ambulatory Payment Classification (APC) Groups (the Panel) for 2008. The purpose of the Panel is to review the APC groups and their associated weights and to advise the Secretary of the Department of Health and Human Services (DHHS) (the Secretary) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) (the Administrator) concerning the clinical integrity of the APC groups and their associated weights. We will consider the Panel's advice as we prepare the final rule that updates the hospital Outpatient Prospective Payment System (OPPS) for CY 2009.

Medicare Program; Meeting of the Medicare Evidence Development and Coverage Advisory Committee--August 20, 2008

Fri, Jun 27 2008 11:00:00 GMT

This notice announces that a public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MedCAC) (``Committee'') will be held on Wednesday, August 20, 2008. The Committee generally provides advice and recommendations concerning the adequacy of scientific evidence needed to determine whether certain medical items and services are reasonable and necessary under the Medicare statute. This meeting will focus on the oncologic indications of 2[F18] FluoroDGlucose (FDG) positron emission tomography (PET) for nine cancers (brain, cervical, small cell lung, ovarian, pancreatic, testicular, prostate, bladder, and kidney). The panel will review the scientific evidence of the impact of PET as part of a management strategy to improve patientcentered outcomes. The panel will also consider data generated under a current national coverage determination that provides coverage for PET for specified cancers when additional data are prospectively collected. The meeting will discuss the vari

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Fri, Jun 27 2008 11:00:00 GMT

Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 2761243. Project: 2009 National Survey on Drug Use and Health(OMB No. 0930 0110)Revision

The National Survey on Drug Use and Health (NSDUH), formerly the National Household Survey on Drug Abuse (NHSDA) is a survey of the civilian, noninstitutionalized population of the United States 12 years old and older. The data are used to determine the prevalence of use of tobacco products, alcohol, illicit substances, and illicit use of prescription drugs. The results are used by SAMHSA, ONDCP, Federal government agencies, and other organizations and researchers to establish policy, direct program activities, and better allocate resources.

In the 2009 NSDUH, one scale measuring im

Agency Forms Undergoing Paperwork Reduction Act Review

Fri, Jun 27 2008 11:00:00 GMT

Restriction on Travel of Persons (OMB Control No. 09200488) Reinstatement without ChangeNational Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

The Centers for Disease Control and Prevention is requesting OMB approval to reinstate without change the information collection request, Rest

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Elimination of Health

Fri, Jun 27 2008 11:00:00 GMT

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

Time and Date: 10 a.m.5 p.m., July 16, 2008 (Closed).

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92463.

Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ``Elimination of Health Disparities through Translation Research (Panel C), FOA CD08001.''

Contact Person for More Information: Susan B. Stanton, D.D.S., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone (404) 6394640.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Regis

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Elimination of Health

Fri, Jun 27 2008 11:00:00 GMT

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

Time and Date: 10 a.m.5 p.m., July 15, 2008 (Closed).

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92463.

Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ``Elimination of Health Disparities through Translation Research (Panel B), FOA CD08001.''

Contact Person for More Information: Susan B. Stanton, D.D.S., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone (404) 6394640.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Regi

Agency Information Collection Request. 60-Day Public Comment Request

Thu, Jun 26 2008 11:00:00 GMT

National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Review of Clinical Trial Planning Grants.

Date: July 2, 2008.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892. (Telephone C

Agency Information Collection Request. 60-Day Public Comment Request

Thu, Jun 26 2008 11:00:00 GMT

In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed information collection request for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency's functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, email your request, including your a

National Institute of Child Health and Human Development; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Attention Trajectories from 5 to 7 Years: A MultiLevel Psychobiological Study.

Date: July 10, 2008.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 208

National Institute of Child Health and Human Development; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institutes of Child Health and Human Development Special Emphasis Panel; Extramural Associates Research Development Award (EARDA).

Date: July 11, 2008.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.

Cont

National Institute of Child Health and Human Development; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Regulation of Placental Signaling and Function by Maternal Nutrient Availability.

Date: July 24, 2008.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD

Office of Clinical and Preventive Services, Division of Nursing Services Nursing Program, Schools of Nursing

Thu, Jun 26 2008 11:00:00 GMT

Announcement Type: Competitive Continuation and New Grants.

Funding Announcement Number: HHS2008IHSNU0001.

Catalog of Federal Domestic Assistance Numbers(s): 93.970

Key Dates:

Application Deadline Date: August 8, 2008.

Review Date: August 18, 2008.

Award Status Notification: August 22, 2008.

Earliest Anticipated Start Date: September 1, 2008. I. Funding Opportunity Description

The Indian Health Service (IHS), Office of Clinical and Preventive Services, Division of Nursing Services, announces a competitive grant application for existing and new grantees under the Nursing Education Program for American Indians/Alaska Natives (AI/AN5). This program is authorized under section 112 of the Indian Health Care Improvement Act, Public Law 94437 as amended. This program is described at 93.970 in the Catalog of Federal Domestic Assistance (CFDA).

The purpose of the Nursing Program Schools of Nursing is to increase the number of nurses, nurse midwives, nurse anesthetists, a

National Institute of Dental & Craniofacial Research; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Dental and Craniofacial Research, Special Emphasis Panel Review R13.

Date: July 30, 2008.

Time: 1:30 p.m. to 2:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6706 Democracy Blvd., Bethesda, MD 20892. (Telephone Conference Call)

Contact Person: Mary Kelly, Scientific Revie

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Bariatric Surgery Ancillary Studies.

Date: July 17, 2008.

Time: 3 p.m. to 4 p.m.

[[Page 36341]]

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. (Tel

National Institute of Environmental Health Sciences; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Environmental Health Sciences, Special Emphasis Panel NIH Pathway to Independence.

Date: July 2324, 2008.

Time: 12 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Sheraton Chapel Hill Hotel, One Europa Drive, Chapel Hill, NC 27517.

Contact Person: Janice B. Allen, PhD, Scientific Review Administ

National Institute of Mental Health; Notice of Closed Meetings

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and
[[Page 36339]]
the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel; Services in NonSpecialty Settings.

Date: June 27, 2008.

Time: 2 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).